MEURISSE, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > Département de chirurgie > Chirurgie abdo, sénologique, endocrine et de transplantation
HONORE, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Département de chirurgie > Chirurgie abdo, sénologique, endocrine et de transplantation
DE ROOVER, Arnaud ; Centre Hospitalier Universitaire de Liège - CHU > Département de chirurgie > Chirurgie abdo, sénologique, endocrine et de transplantation
Language :
French
Title :
Cancers et affections pré-malignes du pancréas approche centralisée et multidisciplinaire au centre de référence de chirurgie Complexe duCHU de Liège
Alternative titles :
[en] Pre-malignant and malignant diseases of the pancreas, a centralized and multidisciplinary approach
Publication date :
May 2021
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Bouvier A, Uhry Z, Jooste V, et al. Focus on an unusual rise in pancreatic cancer incidence in France. Int J Epidemiol 2017;46:1764-72.
Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol 2016;55:1158-60.
Rahib L, Smith B, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74:2913-21.
Cowppli-Bony A, Colonna M, Ligier K, et al. Descriptive epidemiology of cancer in metropolitan France: incidence, survival and prevalence. Bull Cancer 2019;106:617-34.
Ducreux M, Sa Cuhna A, Caramella C, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann oncol 2015;26:56-68.
Neuzillet C, Gaujoux S, Williet N, et al. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up. Dig Liver Dis 2018;50:1257-71.
Daly MB, Pilarski R, Yurgelun MB, et al. NCCN guidelines insights: genetic/familial high risk assessment: braest, ovarian, and pancreatic, version 1.2020. J Natl Compr Canc Netw 2020;18:380-91.
Shindo K, Suenaga M, Fesharakizadeh S, et al. Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. J Clin Oncol 2017;35:3382-90.
Yeo TP. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma. Semin Oncol 2015;42:8-18.
Canto M, Harinck F, Hruban R, et al. International cancer of pancreas screening consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 2013;62:339-47.
Basturk O, Hong S, Wood L, et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol 2015;39:1730-41.
European Study Group on Cystic Tumour of the pancreas. European evidence-based guidelines on pancreatic cystic neoplasm. Gut 2018;67:789-804.
Kulkarni N, Soloff E, Tolat P, et al. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. Abdom Radiol 2020;45:716-28.
Al-Hawari M, Francis I, Chari S, et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the American pancreatic association. Gastroenterology 2014:146;291-304.
Callery MP, Chang KJ, Fishman EK, et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 2009;16:1727-33.
Tempero MA, Malafa MP, Chiorean EG, et al. Pancreatic adenocarcinoma, version 1.2019. J Natl Compr Canc Netw 2019;17:202-10.
Gooiker GA, Lemmens VE, Besselink MG, et al. Impact of centralization of pancreatic cancer surgery on resection rates and survival. Br J Surg 2014;101:1000-5.
Hata T, Motoi F, Ishida M, et al. Effect of hospital volume on surgical outcomes after pancreaticoduodenectomy. Ann Surg 2016;263:664-72.
INAMI. https://www.inami.fgov.be/fr/professionnels/etablissements-services/hopitaux/soins/Pages/chirurgie-pancreasremboursement.aspx. Dernière consultation le 29/03/2021.
Barberan-Garcia A, Ubre M, Roca J, et al. Personalised prehabilitation in high-risk patients undergoing elective major abdominal surgery: a randomized blinded controlled trial. Ann Surg 2018;267:50-6.
Monkman J, Thompson E, Nagaraj S, et al. Targeting epithelial mesenchymal plasticity in pancreatic cancer: a compendium of preclinical discovery in a heterogeneous disease. Cancers (Basel) 2019;11:1745.
Versteijne E, Vogel JA, Besselink MG, et al. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg 2018;105:946-58.
Asbun HJ, Stauffer JA. Laparoscopic vs open pancreaticoduodectomy: overall outcomes and severity of complications using the accordion severity grading system. J Am Coll Surg 2012;215:810-9.
Nassour I, Wang SC, Christie A, et al. Minimally invasive versus open pancreatico-duodenectomy. Ann Surg 2018;268:151-7.
Asbun HJ, Moekotte AL, Vissers FL et al. The Miami international evidence-based guidelines on minimally invasive pancreas resection. Ann Surg 2020;271:1-14.
Poves I, Burdio F, Morato O et al. Comparison of perioperative outcomes between laparoscopic and open approach for pancreatoduodenectomy: the PADULAR randomized controlled trial. Ann Surg 2018;268:1-9.
Palanivelu C, Senthilnathan P, Sabnis SC et al. Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours. Br J Surg 2017;104:1443-50.
